Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

The chelator deferiprone (Ferriprox) decreased brain iron accumulation but accelerated cognitive deterioration in early ...

Alzheimer's is generally characterised by memory loss and other cognitive abilities serious enough to interfere with daily ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

In people with mild cognitive impairment, galantamine, compared to placebo, may make little to no difference in improving memory or the ability to do self-care activities. However, participants who ...

The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...